Anhui Sunhere Pharmaceutical Excipients Co., Ltd. (300452) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Anhui Sunhere Pharmaceutical Excipients Co., Ltd.

Why is Anhui Sunhere Pharmaceutical Excipients Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 12.75% and Operating profit at 5.94% over the last 5 years

With a growth in Net Sales of 1.21%, the company declared Very Positive results in Sep 25

The company has declared positive results in Jan 70 after 7 consecutive negative quarters
OPERATING CASH FLOW(Y) Highest at CNY 206.86 MM
RAW MATERIAL COST(Y) Fallen by -13.96% (YoY)
NET PROFIT(9M) Higher at CNY 131.45 MM

With ROE of 13.35%, it has a fair valuation with a 3.27 Price to Book Value

Over the past year, while the stock has generated a return of 21.85%, its profits have fallen by -22.9%
At the current price, the company has a high dividend yield of 1.8

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Anhui Sunhere Pharmaceutical Excipients Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Anhui Sunhere Pharmaceutical Excipients Co., Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Anhui Sunhere Pharmaceutical Excipients Co., Ltd.

22.86%

0.39

45.34%

China Shanghai Composite

15.17%

1.02

14.86%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

12.75%

EBIT Growth (5y)

5.94%

EBIT to Interest (avg)

62.21

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.29

Sales to Capital Employed (avg)

0.65

Tax Ratio

15.65%

Dividend Payout Ratio

58.82%

Pledged Shares

Institutional Holding

ROCE (avg)

21.33%

ROE (avg)

15.72%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.27

EV to EBIT

22.92

EV to EBITDA

15.91

EV to Capital Employed

4.20

EV to Sales

3.08

PEG Ratio

Dividend Yield

1.84%

ROCE (Latest)

18.34%

ROE (Latest)

13.35%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 206.86 MM

RAW MATERIAL COST(Y)

Fallen by -13.96% (YoY

NET PROFIT(9M)

Higher at CNY 131.45 MM

CASH AND EQV(HY)

Highest at CNY 1,436.01 MM

DEBT-EQUITY RATIO (HY)

Lowest at -30.66 %

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Here's what is working for Anhui Sunhere Pharmaceutical Excipients Co., Ltd.

Operating Cash Flow

Highest at CNY 206.86 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Cash and Eqv

Highest at CNY 1,436.01 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio

Lowest at -30.66 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Net Profit

Higher at CNY 131.45 MM

than preceding 12 month period ended Sep 2025

MOJO Watch

In the nine month period the company has already crossed sales of the previous twelve months

Net Profit (CNY MM)

Raw Material Cost

Fallen by -13.96% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales